English(EN) Few-Shot Bioactivity Prediction with Meta-Learning under Assay Heterogeneity

MetaHeta框架改进药物发现中的生物活性预测

作者 PulseAugur 编辑部 · [1 个来源] · 2026-10-07 04:00

研究人员开发了MetaHeta，一个新颖的元学习框架，旨在改进药物发现早期阶段的生物活性预测。该框架专门解决了试验异质性带来的挑战，而这种异质性会阻碍标准元学习方法的有效性。MetaHeta通过条件化来自相关试验的辅助数据来预测，利用线性和精确注意力机制的组合来实现这一点。MetaHeta的有效性已在ChEMBL和BindingDB的数据集上得到证明，从而增强了少样本生物活性预测能力，并改善了化合物的优先级排序。 AI

影响增强药物发现的少样本学习能力，可能加速新化合物的识别。

排序理由该集群包含一篇学术论文，详细介绍了用于生物活性预测的新机器学习框架。[lever_c_demoted from research: ic=1 ai=1.0]

在 arXiv cs.LG 阅读 →

AI 生成摘要 · Google Gemini · 来自 1 个来源。我们如何撰写摘要 →

本文如何被排名

Signal score: 19 / 100; Composite score across the factors below. Higher = stronger signal that this story matters right now.
Newsworthiness bucket: Tool; 该集群包含一篇学术论文，详细介绍了用于生物活性预测的新机器学习框架。[lever_c_demoted from research: ic=1 ai=1.0]
Source corroboration: Single-source cluster; Only one publisher covered this so far. Single-source stories can still rank when the publisher is high-authority, but they lack cross-source corroboration.
Topics: paper, model release; Editorial topic classification. Feeds into how the story surfaces on /topic/<slug> hub pages and into the per-entity coverage mix.
AI-industry relevance: High; Clearly on-topic for AI-industry coverage.
Story freshness: Breaking (< 6h); Fresh story with cross-source coverage still developing. Ranking may shift as more sources report.

完整方法见我们的编辑标准。

报道来源 [1]

arXiv cs.LG TIER_1 English(EN) · Michal Kmicikiewicz, Tommy Rochussen, Vincent Fortuin, Ewa Szczurek · 2026-10-07 04:00

基于元学习的少样本生物活性预测与试验异质性研究

arXiv:2610.07079v1 Announce Type: new Abstract: Accurate bioactivity prediction is a central challenge in early-stage drug discovery, as individual assays often contain too few measurements to train reliable models independently. Meta-learning offers a principled approach to this…

本文如何被排名

报道来源 [1]

基于元学习的少样本生物活性预测与试验异质性研究

相关实体

相关话题